[SRNE] YoY Annual Result on 31-Dec-2022 [#FY]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
15-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#FY]
Profit Trend
YoY- -33.53%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 62,839 52,904 39,986 31,432 21,193 151,856 8,152 40.52%
PBT -561,747 -462,528 -310,580 -359,576 -213,781 15,315 -64,833 43.29%
Tax -2,416 -33,516 -2,014 -473 -6,274 -36,038 -896 17.96%
NP -572,843 -429,012 -308,566 -359,103 -203,540 9,061 -60,923 45.25%
Tax Rate - - - - - 235.31% - -
Total Cost 635,682 481,916 348,552 390,535 224,733 142,795 69,075 44.73%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -911.60 -810.93 -771.69 -1,142.48 -960.41 5.97 -747.34 3.36%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -1.37 -1.46 -1.34 -2.56 -1.92 0.13 -1.21 2.09%
EPS Diluted -1.37 -1.46 -1.34 -2.56 -1.92 0.13 -1.21 2.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.